Ignite Creation Date:
2024-05-06 @ 2:28 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04321499
Status:
COMPLETED
Last Update Posted:
2020-03-25
First Post:
2020-03-23
Brief Title:
SHOX2_PTGER4 DNA Methlyation in Lung Cancer
Sponsor:
University Hospital Essen
Organization:
University Hospital Essen
Study Overview
Official Title:
Establishing a Non-invasive Diagnostic Biomarker Test for Early Diagnosis of Lung Cancer
Status:
COMPLETED
Status Verified Date:
2020-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Epi1
Brief Summary:
Data on SHOX2 and PTGER4 DNA Methylation suggest possible use as a biomarker for early lung cancer diagnosis
In this study a control group consisting of COPD patients with a CT-scan of the chest no older than 6 weeks and a control group of patients with a nodule and ruled out diagnosis of lung cancer will be included
SHOX2 and PTGER4 will be analyzed via PCR
In this study a control group consisting of COPD patients with a CT-scan of the chest no older than 6 weeks and a control group of patients with a nodule and ruled out diagnosis of lung cancer will be included
SHOX2 and PTGER4 will be analyzed via PCR
Detailed Description:
Data on SHOX2 and PTGER4 DNA Methylation suggest possible use as a biomarker for early lung cancer diagnosis
In this study a control group consisting of COPD patients with a CT-scan of the chest no older than 6 weeks and a control group of patients with a nodule and ruled out diagnosis of lung cancer will be included
A total of 150 patients will be enrolled in this study SHOX2 and PTGER4 will be analyzed via PCR of blood plasma samples
In this study a control group consisting of COPD patients with a CT-scan of the chest no older than 6 weeks and a control group of patients with a nodule and ruled out diagnosis of lung cancer will be included
A total of 150 patients will be enrolled in this study SHOX2 and PTGER4 will be analyzed via PCR of blood plasma samples
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None